TARE Y-90 therapy is increasingly recognized as an effective treatment option for liver cancer due to its ability to directly target tumors. By utilizing radiation from Yttrium-90, this therapy helps shrink tumor size, control cancer progression, and extend patient survival up to 2–3 years. In addition, TARE Y-90 can reduce symptoms, allowing patients to maintain a better quality of life throughout their treatment.
In Indonesia, TARE Y-90 therapy is available at Mandaya Royal Hospital Puri and is performed by dr. Sugianto Santoso, Sp.Rad (K)RI, an interventional radiology specialist experienced in various minimally invasive procedures. Supported by advanced medical technology and strong clinical expertise, patients can receive more precise and optimal liver cancer treatment.
Contents
How effective is TARE Y-90 therapy for liver cancer?
TARE Y-90 is a liver cancer treatment that has demonstrated positive outcomes across various stages of the disease. It not only helps control tumor growth but also extends life expectancy and improves quality of life by reducing symptoms. Today, it is also increasingly used as an initial step before further treatments such as surgery.
1. Improves life expectancy and quality of life
TARE Y-90 therapy can extend the life expectancy of patients with inoperable liver cancer from just a few months to approximately 2–3 years. It also helps relieve symptoms, enabling patients to carry out daily activities more comfortably.
2. Effectiveness in early-stage liver cancer
In early-stage liver cancer, TARE Y-90 has been shown to shrink tumors or stop their growth. Several studies indicate that its outcomes are comparable to, or even better than, other treatment methods in certain cases. Patients at this stage tend to respond better because the disease is still localized.
3. Benefits in intermediate to advanced stages
TARE Y-90 is also beneficial for patients with intermediate to advanced liver cancer. Despite the more complex condition, this therapy can still help prolong survival and reduce symptoms experienced by patients.
4. Helps patients become eligible for liver transplantation
One of the key advantages of TARE Y-90 is its ability to shrink tumors (downstaging), allowing patients who were previously not eligible for liver transplantation to become candidates. This opens up more treatment possibilities in the future.
5. Improves chances of successful transplantation
With the help of TARE Y-90 therapy, some patients have successfully undergone liver transplantation with favorable outcomes. This shows that TARE Y-90 not only controls cancer but can also serve as a bridge to more definitive treatments.
How does TARE Y-90 therapy work without surgery?
In general, the procedure involves the following steps:
- A mapping angiogram is first performed to identify the blood vessels supplying the tumor and plan the optimal delivery route.
- Microscopic particles containing Y-90 are injected into the blood vessels leading to the liver tumor.
- These particles travel through the bloodstream directly to the tumor site.
- Once they reach the tumor, they release high-dose radiation to destroy cancer cells.
- The radiation is highly targeted, minimizing damage to surrounding healthy liver tissue.
- This process helps control tumor growth, extend survival, reduce symptoms, and improve quality of life.
Who is eligible for TARE Y-90 therapy?
TARE Y-90 therapy is generally recommended for patients with liver cancer who are not suitable for surgery. It can also be used in certain conditions to control tumor progression while preserving liver function and potentially enabling further treatments in the future.
Some conditions that may be considered for TARE Y-90 therapy include:
- Primary liver cancer originating in the liver
- Cancer that has spread to the liver (metastasis)
- Tumors that cannot be surgically removed, for example due to proximity to major blood vessels
- Conditions requiring tumor control while maintaining liver function
- Patients being prepared for further treatments such as surgery or liver transplantation after tumor reduction
TARE Y-90 Therapy at Mandaya Royal Hospital Puri with dr. Sugi, Sp.Rad (K)RI
TARE Y-90 therapy at Mandaya Royal Hospital Puri is performed by dr. Sugianto Santoso, Sp.Rad (K)RI, a radiology specialist with a subspecialty in interventional radiology who is experienced in various minimally invasive procedures using advanced imaging technology. He completed his medical degree at Maranatha Christian University in Bandung and pursued his radiology specialization at the University of Indonesia.
In his clinical practice, dr. Sugianto Santoso treats a wide range of medical conditions without the need for open surgery, including liver cancer and other complex cases. His expertise includes interventional techniques such as Radiofrequency Ablation (RFA) for thyroid nodules, Microwave Ablation (MWA) for tumors and liver cancer, and Transarterial Chemoembolization (TACE) as a liver cancer treatment method.
With the support of advanced medical technology and a minimally invasive approach, dr. Sugi provides safer, more precise, and effective treatment options. TARE Y-90 therapy is one of the modern solutions offered at Mandaya Royal Hospital Puri for treating liver cancer without surgery, alongside other interventional procedures.
To make your visit to Mandaya Royal Hospital Puri more convenient, you can use the WhatsApp Chat feature, Book Appointment service, or the Care Dokter application available on Google Play and the App Store to check queue numbers and access more information.
The information on this page is intended for educational and general purposes only and does not represent the full range of medical services provided by each doctor. For appropriate treatment based on your condition, it is recommended to consult directly with the respective doctor.
If you have any questions or need further information, please contact our call center at 0811-1900-2000.
